Intech Investment Management LLC Cytokinetics Inc Transaction History
Intech Investment Management LLC
- $10 Billion
- Q4 2024
A detailed history of Intech Investment Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Intech Investment Management LLC holds 50,273 shares of CYTK stock, worth $2.35 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
50,273
Previous 32,671
53.88%
Holding current value
$2.35 Million
Previous $1.73 Million
37.04%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$684 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$556 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$502 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$368 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$288 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.39B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...